HRMY: Harmony Biosciences Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2,307.49
Enterprise Value ($M) 2,102.97
Book Value ($M) 596.80
Book Value / Share 10.46
Price / Book 3.87
NCAV ($M) 191.07
NCAV / Share 3.35
Price / NCAV 12.08

Profitability (mra)
Return on Invested Capital (ROIC) 0.16
Return on Assets (ROA) 0.15
Return on Equity (ROE) 0.26

Liquidity (mrq)
Quick Ratio 3.20
Current Ratio 3.24

Balance Sheet (mrq) ($M)
Current Assets 522.40
Assets 928.13
Liabilities 331.33
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Valor IV Pharma Holdings, LLC 19.20 0.10
02-13 13G/A Vanguard Group Inc 6.27 12.91
02-09 13G/A Fmr Llc 9.01 -5.48
01-24 13G/A BlackRock, Inc. 10.20 -2.11

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-10-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-28 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1)
2024-02-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-22 78,234 465,534 16.81
2025-01-21 176,108 757,472 23.25
2025-01-17 160,530 518,983 30.93

(click for more detail)

Similar Companies
GANX – Gain Therapeutics, Inc. GHRS – GH Research PLC
HCWB – HCW Biologics Inc. HROW – Harrow, Inc.
IKNA – Ikena Oncology, Inc.


Financial data and stock pages provided by
Fintel.io